title: Combination of mometasone furoate and oxymetazoline for the treatment of adenoid hypertrophy concomitant with allergic rhinitis: A randomized controlled trial.
abstract: In the clinic, approximately 30% of children with adenoid hypertrophy (AH) concomitant with allergic rhinitis (AR) report poor responses to intranasal steroids. To determine whether the combination of mometasone furoate (MF) and oxymetazoline (OXY) is more effective than either agent alone, we performed a two-stage, parallel, randomized, double-blind, double-dummy, clinical trial with 240 AH children with concomitant perennial AR. During the first stage, all children were randomly assigned to the MF or control group for six weeks of treatment. During the second stage, the non-responders from stage one were randomly assigned to 4 groups for 8 weeks of treatment that involved receiving the following treatments: MF/OXY, MF/placebo, placebo/OXY, or placebo/placebo. During the first stage of treatment, 39% of the responders treated with MF achieved greater reductions in total and individual symptom scores than did those on placebo. During the second stage of treatment, the nasal congestion scores of the MF/OXY group significantly decreased. The adenoid/choana ratio of the MF/OXY-treated group decreased and the nasal volume increased significantly. Our results suggest that the combination of OXY and MF is effective and safe for the treatment of AH children with concomitant AR and has a rapid onset of action.
authors.affiliation: Department of Otolaryngology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
authors.forename: Wenlong
authors.initials: W
authors.lastname: Liu
authors.affiliation: Department of Otolaryngology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
authors.forename: Lifeng
authors.initials: L
authors.lastname: Zhou
authors.affiliation: Department of Otolaryngology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
authors.forename: Qingxiang
authors.initials: Q
authors.lastname: Zeng
authors.affiliation: Department of Otolaryngology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
authors.forename: Renzhong
authors.initials: R
authors.lastname: Luo
mesh_terms: D000234:Adenoids / Q000187:drug effects / Q000473:pathology*; D016022:Case-Control Studies; D002648:Child; D003710:Demography; D005260:Female; D006801:Humans; D006984:Hypertrophy; D008297:Male; D000068656:Mometasone Furoate / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D009666:Nose / Q000473:pathology; D010109:Oxymetazoline / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D010349:Patient Compliance; D012221:Rhinitis, Allergic, Perennial / Q000150:complications* / Q000188:drug therapy*
chemical_list: D000068656:Mometasone Furoate; D010109:Oxymetazoline